Ceftriaxone for Post-Treatment Lyme Disease

Clinical trial NCT06785402 · WITHDRAWN

Trial details

NCT number: NCT06785402
Sponsor: Hackensack Meridian Health
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Post-Treatment Lyme Disease Syndrome

Start date: 2026-05-14
Primary completion: 2026-05-14
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.